Back to EYPT

EyePoint Pharmaceuticals, Inc. 8-K

Accession 0001193125-19-121055

Filing information

CIK
0001314102
Report date
2019-04-22
Filing date
2019-04-26
Form
8-K
Primary document
d719091d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.